TMVAX | VSCAX | TMVAX / VSCAX | |
Total Expense Ratio | 1.34 | 1.12 | 120% |
Annual Report Gross Expense Ratio | 1.64 | 1.12 | 146% |
Fund Existence | 21 years | 26 years | - |
Gain YTD | 1.075 | 3.998 | 27% |
Front Load | 6% | 6% | 105% |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 108M | 7.03B | 2% |
Annual Yield % from dividends | 1.60 | 0.35 | 464% |
Returns for 1 year | -4.21 | 5.38 | -78% |
Returns for 3 years | -2.01 | 42.53 | -5% |
Returns for 5 years | 37.90 | 124.82 | 30% |
Returns for 10 years | 5.67 | 27.85 | 20% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HULEX | 34.57 | 0.13 | +0.38% |
Huber Select Large Cap Value Instl | |||
CMTFX | 103.55 | 0.24 | +0.23% |
Columbia Global Technology Growth Inst | |||
TQGEX | 20.27 | 0.04 | +0.20% |
T. Rowe Price Integrated Global Eq | |||
BGDVX | 14.87 | 0.01 | +0.07% |
BlackRock GA Disciplined Volatility Eq K | |||
AEPFX | 61.40 | -0.32 | -0.52% |
American Funds EUPAC F2 |